Home › Funds › SABBY MANAGEMENT, LLC › BCTX

SABBY MANAGEMENT, LLC position in BCTX

BRIACELL THERAPEUTICS CORP · Health Care

SABBY MANAGEMENT, LLC reported holding 80,721 shares of BCTX (BRIACELL THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$262K, representing 1.91% of its reported portfolio and ranking #11 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed BCTX holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)80.72K sh
Reported value held$261.54K
Portfolio Weight1.91%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SABBY MANAGEMENT, LLC's BCTX position evolved

SABBY MANAGEMENT, LLC first disclosed a stake in BCTX in Q3 2023 at 712 shares (US$445.0M). Across 6 filings, SABBY MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 80,721 shares valued at US$262K — an increase of 6,806 shares quarter over quarter.. Notable position changes include a 53% trim in Q4 2023 (shares fell 51% over the following quarter), a 10055% increase in Q1 2024 (shares fell 60% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 712 $445.00M New
Q4 2023 337 $197.15M Reduce
Q1 2024 34.22K $97.88K Add
Q2 2025 39.53K $116.22K New
Q1 2026 73.92K $309.70K New
Q2 2026 80.72K $261.54K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCTX and 13F data

BCTX (BRIACELL THERAPEUTICS CORP) is a Health Care company. 17 other funds we track also report a position in BCTX — the largest reported positions include IRIDIAN ASSET MANAGEMENT LLC/CT (US$211K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCTX

All BCTX fund holders →

FAQ

How long has SABBY MANAGEMENT, LLC held BCTX?

SABBY MANAGEMENT, LLC has disclosed BCTX holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is SABBY MANAGEMENT, LLC's current position in BCTX?

As of Q2 2026, SABBY MANAGEMENT, LLC holds 80.72K shares of BCTX (BRIACELL THERAPEUTICS CORP), valued at $261.54K, representing 1.91% of its reported portfolio and ranking #11.

Has SABBY MANAGEMENT, LLC been buying or selling BCTX?

In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC increased its position in BCTX.

Which other funds hold BCTX?

Other major institutional holders of BCTX include IRIDIAN ASSET MANAGEMENT LLC/CT, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.